Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
1 Commonwealth Lane, Singapore
SEC filing record 1 source field available
Fiscal year end
31 December
CytoMed Therapeutics Ltd has filed 131 SEC EDGAR filings since 28 Sep 2021

SEC filing history

Showing 76-100 of 131 matching filings.

Per page
25
Current page
4
6-K File 001-41677

6-K filing

Filing date
17 Nov 2023
Reporting date
30 Jun 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-41677

6-K filing

Filing date
25 Sep 2023
Reporting date
25 Sep 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-41677

6-K filing

Filing date
01 Aug 2023
Reporting date
01 Aug 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-41677

6-K filing

Filing date
06 Jul 2023
Reporting date
06 Jul 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-94045

SC 13D filing

Filing date
19 May 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
20-F File 001-41677

20-F filing

Filing date
01 May 2023
Reporting date
31 Dec 2022
Next action
Verify source filing
SC 13G File 005-94045

SC 13G filing

Filing date
24 Apr 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-94045

SC 13D filing

Filing date
21 Apr 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-41677

6-K filing

Filing date
18 Apr 2023
Reporting date
18 Apr 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
424B4 File 333-268456

424B4 filing

Filing date
17 Apr 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
17 Apr 2023
Reporting date
31 Mar 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
17 Apr 2023
Reporting date
31 Mar 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
14 Apr 2023
Reporting date
31 Mar 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
14 Apr 2023
Reporting date
31 Mar 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
14 Apr 2023
Reporting date
31 Mar 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
14 Apr 2023
Reporting date
31 Mar 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
14 Apr 2023
Reporting date
31 Mar 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
14 Apr 2023
Reporting date
31 Mar 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
14 Apr 2023
Reporting date
31 Mar 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
14 Apr 2023
Reporting date
31 Mar 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
CERT File 001-41677

8A CERT

Filing date
14 Apr 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SEC STAFF LETTER

SEC STAFF LETTER filing

Filing date
31 Mar 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-268456

EFFECT filing

Filing date
31 Mar 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
31 Mar 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
FWP File 333-268456

FWP filing

Filing date
31 Mar 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .